Revolution Medicines Files 8-K
Ticker: RVMDW · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1628171
| Field | Detail |
|---|---|
| Company | Revolution Medicines, Inc. (RVMDW) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: RVMD
TL;DR
RVMD filed an 8-K on 10/16/25 for 'Other Events' - details TBD.
AI Summary
On October 16, 2025, Revolution Medicines, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Revolution Medicines, Inc. has reported an event to the SEC, which could be material to investors. However, the specific nature of the event is not detailed in this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for 'Other Events' without immediate disclosure of significant financial or operational changes, thus posing low immediate risk.
Key Players & Entities
- Revolution Medicines, Inc. (company) — Registrant
- October 16, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-39219 (identifier) — Commission File Number
- 47-2029180 (identifier) — IRS Employer Identification No.
- 700 Saginaw Drive (address) — Principal Executive Offices
- Redwood City, California (location) — Principal Executive Offices Location
- 94063 (zip_code) — Principal Executive Offices Zip Code
- (650) 481-6801 (phone_number) — Registrant's telephone number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated October 16, 2025.
What is the company's Central Index Key (CIK)?
The company's CIK is 0001628171.
In which state was Revolution Medicines, Inc. incorporated?
Revolution Medicines, Inc. was incorporated in Delaware.
What is the Commission File Number for Revolution Medicines, Inc.?
The Commission File Number is 001-39219.
What is the primary item of disclosure for this 8-K filing?
The primary item of disclosure is 'Other Events'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on October 17, 2025 regarding Revolution Medicines, Inc. (RVMDW).